A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer
Condition(s):Metastatic Pancreatic Cancer; Metastatic Pancreatic AdenocarcinomaLast Updated:March 26, 2024Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Metastatic Pancreatic Cancer; Metastatic Pancreatic AdenocarcinomaLast Updated:March 26, 2024Active, not recruiting
Condition(s):Pancreatic Neoplasm; Pancreatic Adenocarcinoma; Borderline Resectable Pancreatic AdenocarcinomaLast Updated:May 23, 2023Recruiting
Condition(s):Pancreatic CancerLast Updated:March 6, 2024Recruiting
Condition(s):Pancreatic Ductal Adenocarcinoma; Resectable Pancreatic CancerLast Updated:November 22, 2023Recruiting
Condition(s):Pancreatic Ductal AdenocarcinomaLast Updated:February 25, 2022Unknown status
Condition(s):Adenocarcinoma of the PancreasLast Updated:January 12, 2024Recruiting
Condition(s):Advanced Pancreatic CancerLast Updated:August 11, 2020Unknown status
Condition(s):Resected Pancreatic AdenocarcinomaLast Updated:July 29, 2021Unknown status
Condition(s):Pancreatic CancerLast Updated:December 31, 2020Unknown status
Condition(s):Acinar Cell Adenocarcinoma of the Pancreas; Duct Cell Adenocarcinoma of the Pancreas; Recurrent Pancreatic Cancer; Stage IV Pancreatic CancerLast Updated:July 12, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.